Cargando…
Metabolomic and Lipidomic Profiling of Bone Marrow Plasma Differentiates Patients with Monoclonal Gammopathy of Undetermined Significance from Multiple Myeloma
Oncogenic drivers of progression of monoclonal gammopathy of undetermined significance (MGUS) to multiple myeloma (MM) such as c-MYC have downstream effects on intracellular metabolic pathways of clonal plasma cells (PCs). Thus, extracellular environments such as the bone marrow (BM) plasma likely h...
Autores principales: | Gonsalves, Wilson I., Broniowska, Katarzyna, Jessen, Erik, Petterson, Xuan-Mai, Bush, Alexander Graham, Gransee, Jaimee, Lacy, Martha Q., Hitosugi, Taro, Kumar, Shaji K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314797/ https://www.ncbi.nlm.nih.gov/pubmed/32581232 http://dx.doi.org/10.1038/s41598-020-67105-3 |
Ejemplares similares
-
Prognosis of young patients with monoclonal gammopathy of undetermined significance (MGUS)
por: Pang, Li, et al.
Publicado: (2021) -
Association of Pulmonary Hypertension and Monoclonal Gammopathy of Undetermined Significance
por: Lyle, Melissa A., et al.
Publicado: (2022) -
Autoimmune manifestations in patients with multiple myeloma and monoclonal gammopathy of undetermined significance()
por: Shimanovsky, Alexei, et al.
Publicado: (2016) -
Distinct Nuclear Organization of Telomeres and Centromeres in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma
por: Yu, Pak Lok Ivan, et al.
Publicado: (2019) -
Risk factors for severe infection and mortality in COVID-19 and monoclonal gammopathy of undetermined significance
por: Ho, Matthew, et al.
Publicado: (2022)